Grespo AB
556710-0275ActiveYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Biomedical Company / Biotech Firmgrespo.se
Yleiskatsaus
- 0
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2006
- Perustettu
Kuvaus
Grespo is a young biomedical company based in Sweden specializing in the prevention and treatment of Central Nervous System (CNS) diseases. The core of their research focuses on leveraging the therapeutic effects of the substance 2-oxoglutarate (2-OX) within the body. Their primary clinical targets...
Tunnisteet
B2BB2CTechnologyPharmaceuticals
Polku Therapeutics Oy